Stem cell therapy for male hair loss
Treatments studied
Part of Skin clinical trials.
This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 25 and 59 years old.
- You have male pattern baldness that matches a specific severity scale (grades 2 to 6).
- You are not currently using hair loss medications like minoxidil or certain anti-androgen drugs.
- You have not had a platelet-rich plasma (PRP) treatment in the last 6 months.
- You do not have a history of abnormal scarring, bleeding problems, or thyroid conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using exosomes (tiny particles that help cells communicate) for male pattern baldness. It may help regrow hair or slow further loss.
This study tests whether microneedling, a procedure that uses tiny needles to stimulate the scalp, can help treat male pattern baldness. It may help regrow hair in men with moderate to advanced hair loss.
This study compares two treatments for male pattern hair loss: a special injection made from your own fat cells (called stromal vascular fraction) versus a platelet-rich plasma (PRP) injection. Both are designed to help regrow hair.
This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.
This trial tests whether injections of exosomes (tiny particles from cells) can help regrow hair in men with mild to moderate male pattern baldness. It may offer a new treatment option without surgery.
This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.